ASLM2023 Set to Take Place as In-Person Event in December at South Africa
By LabMedica International staff writers Posted on 20 Jul 2023 |

The African Society for Laboratory Medicine (ASLM, Addis Ababa, Ethiopia), a leading pan-African organization committed to advancing laboratory medicine and healthcare, has announced that its much-anticipated ASLM2023 conference will be held from 12 – 15 December 2023 at the Cape Town International Convention Centre (CTICC) in South Africa. This groundbreaking in-person event signifies a crucial turning point as ASLM's first face-to-face conference post-COVID-19, bringing together over 1200 professionals, experts, and researchers to examine the transformative potential of laboratory medicine and reshape Africa's healthcare future.
ASLM consistently champions the crucial role of laboratory medicine in African healthcare. Collaborating with key global, regional, and country stakeholders, the organization strengthens laboratory and diagnostic services and networks, ensuring global laboratory and diagnostic agendas mirror the country’s needs and priorities. ASLM implements targeted, multi-disciplinary, multi-stakeholder interventions based on evidence, globally accepted best practices, and standards. Moreover, ASLM serves as an important advocate for laboratory professionals in Africa, facilitating technical assistance provision by African experts.
Under the theme "Shaping Laboratory Systems and Diagnostic Services for the 21st Century: Embracing Change," the ASLM2023 conference will delve into innovative strategies to redefine laboratory medicine and healthcare in Africa. The conference will kick off with an opening ceremony on 12 December, followed by a three-day scientific program. Day 1 will examine the challenges and opportunities being faced by laboratory medicine in the 21st century. Day 2 will investigate emerging solutions designed to adapt to the dynamic field of laboratory medicine. Day 3 will concentrate on the path towards transforming laboratory medicine for this century. The conference will assemble experts from Africa and beyond to share their knowledge and experience. Activities will include plenary lectures, symposia, round tables, abstract-driven oral and poster sessions, exhibitions, and workshops.
ASLM2023 will have an impressive line-up of speakers, including Ambassador Dr. John Nkengasong, former Director of Africa CDC and the current US Global AIDS Coordinator for PEPFAR who will be presenting the ASLM2023 keynote speech and sharing invaluable insights from his more than 30 years of experience as public health leader. Among those leading the conference as co-chairs are Dr. Kamy Chetty, Chief Executive Officer of the National Health Laboratory Service, South Africa, and Professor Abderrahmane Maaroufi, Director of the Institut Pasteur, Morocco. The scientific co-chairs are Dr. Pascale Ondoa, Director of Science and New Initiatives at ASLM, and Professor Iruka Okeke, Professor at the University of Ibadan, Nigeria.
“As a pan-African professional society, ASLM effectively coordinates and mobilizes various actors to enhance local access to world-class diagnostic services, ensuring the health of African communities,” said Mr. Nqobile Ndlovu, CEO of ASLM, emphasizing the organization’s commitment. “Through this conference, we aim to bring together professionals, experts, and researchers in laboratory medicine to discuss advancements, share knowledge, and collaborate on addressing healthcare challenges in Africa.”
“We are excited to host the ASLM2023 conference in South Africa, and welcome all participants to Cape Town,” said Dr. Chetty. “This event offers a valuable platform for laboratory medicine professionals to come together, share insights, and shape the future of diagnostic services in Africa.”
“Nowhere else can you find an event of this caliber, which aspires to define the foundations of a new model for Africa’s medical laboratory systems for this century,” said Prof Maaroufi. “It’s an honor to co-chair ASLM2023 with Dr. Chetty and get the opportunity to share information and ideas with our colleagues from around the world.”
Related Links:
ASLM
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more
Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
HIV diagnostic methods have traditionally relied on detecting HIV-specific antibodies, which typically appear weeks after infection. This delayed detection has hindered early diagnosis, complicating patient... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreInnovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more